ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M03AC11 | G | Cisatracurium (besylate) - 20mg/10ml | 9766 | 78618/1 | SISACURE | 20mg/10ml | 5 x 10ml | Injectable solution | Infusion/IV | Abela Frères S.A.L. | Hikma Italia SpA | Italy | 1,408,347 L.L | 23.08 | A2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M03AC11 | B | Cisatracurium (besylate) - 20mg/10ml | 9489 | 22018/1 | NIMBEX | 20mg/10ml | 5 x 10ml | Injectable solution | Infusion/IV | Abela Frères S.A.L. | GlaxoSmithKline Manufacturing SpA | Italy | 2,139,397 L.L | 23.08 | B | Aspen Pharma Trading Limited | Ireland | 2/5/2024 | 0 |